IHE
·NYSE
--
--(--)
--
--(--)
Key Stats
Assets Under Management
841.42MUSD
Fund Flows (1Y)
66.10MUSD
Dividend Yield
1.76%
Discount/Premium to NAV
0.02%
Shares Outstanding
9.90M
Expense Ratio
0.38%
About iShares U.S. Pharmaceuticals ETF
Issuer
BlackRock Fund Advisors
Brand
iShares
Inception Date
May 1, 2006
Structure
Open-Ended Fund
Index Tracked
Dow Jones U.S. Select Pharmaceuticals Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
IHE tracks a broad index of US pharmaceutical companies. The fund provides exposure to the manufacturers of prescription or over-the-counter drugs, such as aspirin, cold remedies and birth control pills. The index also includes vaccine producers. IHE may also include companies of all sizes, ranging from large- to small-cap. The index weights its constituents by market cap, with a cap of up to 22.5% per individual company and is rebalanced quarterly. IHE uses a sampling strategy that involves investing in a representative sample of securities that collectively has an investment profile similar to that of an applicable underlying index. Index components are selected on an annual basis.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharmaceuticals
Strategy
Vanilla
Geography
U.S.
Weighting Scheme
Market Cap
Selection Criteria
Market cap
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | +3.71% | +20.99% | +28.86% | +29.51% | +38.85% | +45.93% |
NAV Total Return | +5.07% | +21.71% | +32.06% | +32.05% | +46.19% | +58.35% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
99.37%
0.63%
Category
Ratio
North America
99.37%
Asia
0.63%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Growth
Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.
Top 10 Holdings
Symbol
Ratio
LLY
Eli Lilly
26.32%
JNJ
Johnson & Johnson
22.27%
MRK
Merck
4.50%
VTRS
Viatris
4.38%
BMY
Bristol-Myers Squibb
4.25%
RPRX
Royalty Pharma
3.99%
PFE
Pfizer
3.83%
ELAN
Elanco Animal Health
3.45%
JAZZ
Jazz Pharmaceuticals
3.17%
ZTS
Zoetis
3.09%
Top 10 Weight 79.25%
47 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-12-16 | 2025-12-16 | 2025-12-19 | 0.585 |
| 2025-09-16 | 2025-09-16 | 2025-09-19 | 0.312 |
| 2025-06-16 | 2025-06-16 | 2025-06-20 | 0.307 |
| 2025-03-18 | 2025-03-18 | 2025-03-21 | 0.292 |
| 2024-12-17 | 2024-12-17 | 2024-12-20 | 0.211 |
| 2024-09-25 | 2024-09-25 | 2024-09-30 | 0.359 |
| 2024-06-11 | 2024-06-11 | 2024-06-17 | 0.294 |
Show more
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
